EAF2 Antikörper (AA 150-200)
-
- Target Alle EAF2 Antikörper anzeigen
- EAF2 (ELL Associated Factor 2 (EAF2))
-
Bindungsspezifität
- AA 150-200
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EAF2 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Verwendungszweck
- Rabbit anti-EAF2 IHC Antibody, Affinity Purified
- Homologie
- Orangutan,Monkey,Gorilla,Chimpanzee,Crab-eating macaque,White-tufted-ear marmoset
- Aufreinigung
- Affinity Purified
- Immunogen
- Between AA 150 and 200
- Isotyp
- IgG
- Top Product
- Discover our top product EAF2 Primärantikörper
-
-
- Applikationshinweise
- 1:100 - 1:500
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 250 μg/mL
- Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- EAF2 (ELL Associated Factor 2 (EAF2))
- Andere Bezeichnung
- EAF2 (EAF2 Produkte)
- Hintergrund
- Background: ELL-associated factor 2 (EAF2) acts as a transcriptional transactivator of TCEA1 elongation activity. It is also a transcriptional transactivator of ELL (eleven nineteen lysine-rich leukemia) 1 and ELL2 elongation activities. EAF2 has been shown to be a potent inducer of apoptosis in prostatic and non-prostatic cell lines and to inhibit prostate tumor growth in vivo [taken from the Universal Protein Resource (UniProt) Q96CJ1].
- Gen-ID
- 55840
- NCBI Accession
- NP_060926
- UniProt
- Q96CJ1
-